{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:39:13Z","timestamp":1787981953806,"version":"build-2784847793"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaoncol.2020.0109","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:46:36Z","timestamp":1585223196000},"page":"735","source":"Crossref","is-referenced-by-count":101,"title":["Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Robert T.","family":"Dess","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"},{"name":"Department of Biostatistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil K.","family":"Jairath","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar U.","family":"Kishan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Wallington","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon A.","family":"Mahal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachery S.","family":"Zumsteg","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cedars-Sinai Medical Center, West Hollywood, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Den","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila A.","family":"Gharzai","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Jaworski","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Reichert","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Schaeffer","sequence":"additional","affiliation":[{"name":"Department of Urology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sartor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane Cancer Center, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Robert","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Duke Health, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sutter Medical Group, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Michalski","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Schipper","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"},{"name":"Department of Biostatistics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Dignam","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Pisansky","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Zietman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cedars-Sinai Medical Center, West Hollywood, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Efstathiou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Y.","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco"},{"name":"Department of Urology, University of California, San Francisco"},{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William U.","family":"Shipley","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"coi200003r1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.2018.19941","article-title":"Use of active surveillance or watchful waiting for low-risk prostate cancer and management trends across risk groups in the United States, 2010-2015.","volume":"321","author":"Mahal","year":"2019","journal-title":"JAMA"},{"issue":"28","key":"coi200003r2","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","article-title":"Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.","volume":"23","author":"Stephenson","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi200003r3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.eururo.2015.06.020","article-title":"Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.","volume":"68","author":"Abdollah","year":"2015","journal-title":"Eur Urol"},{"issue":"30","key":"coi200003r4","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy.","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"coi200003r5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer.","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"issue":"32","key":"coi200003r6","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1200\/JCO.2016.68.3425","article-title":"Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer.","volume":"34","author":"Stish","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3 Pt 1","key":"coi200003r7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.juro.2016.08.106","article-title":"Very early salvage radiotherapy improves distant metastasis-free survival.","volume":"197","author":"Abugharib","year":"2017","journal-title":"J Urol"},{"issue":"6","key":"coi200003r8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial.","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"issue":"21","key":"coi200003r9","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1001\/jama.2011.1745","article-title":"Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.","volume":"306","author":"Nguyen","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"coi200003r10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaoncol.2016.3662","article-title":"Association between androgen deprivation therapy and risk of dementia.","volume":"3","author":"Nead","year":"2017","journal-title":"JAMA Oncol"},{"key":"coi200003r11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1553","article-title":"Credibility of claims of subgroup effects in randomised controlled trials: systematic review.","volume":"344","author":"Sun","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"coi200003r12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","article-title":"Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.","volume":"17","author":"Carrie","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"coi200003r13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ijrobp.2018.08.052","article-title":"Short term androgen deprivation therapy without or with pelvic lymph node treatment added to prostate bed only salvage radiotherapy: the NRG Oncology\/RTOG 0534 SPPORT trial.","volume":"102","author":"Pollack","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi200003r14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"Journal of the Royal Statistical SocietyB"},{"issue":"282","key":"coi200003r15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"446","key":"coi200003r16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"Journal of the American Statistical Association"},{"issue":"6","key":"coi200003r17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Applications of crude incidence curves.","volume":"11","author":"Korn","year":"1992","journal-title":"Stat Med"},{"issue":"6","key":"coi200003r18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jclinepi.2012.09.017","article-title":"A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.","volume":"66","author":"Latouche","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"coi200003r19","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","article-title":"The use and interpretation of competing risks regression models.","volume":"18","author":"Dignam","year":"2012","journal-title":"Clin Cancer Res"},{"key":"coi200003r20","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"coi200003r21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJM198908173210702","article-title":"A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.","volume":"321","author":"Crawford","year":"1989","journal-title":"N Engl J Med"},{"issue":"3","key":"coi200003r22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ijrobp.2018.06.037","article-title":"Evidence-based risk stratification to guide hormone therapy use with salvage radiation therapy for prostate cancer.","volume":"102","author":"Spratt","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi200003r23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2017.06.027","article-title":"A systematic review and framework for the use of hormone therapy with salvage radiation therapy for recurrent prostate cancer.","volume":"73","author":"Spratt","year":"2018","journal-title":"Eur Urol"},{"issue":"12","key":"coi200003r24","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol"},{"issue":"27","key":"coi200003r25","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi200003r26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer.","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"coi200003r27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2016.06.2445","article-title":"Late radiation and cardiovascular adverse effects after androgen deprivation and high-dose radiation therapy in prostate cancer: Results from the DART 01\/05 randomized phase 3 trial.","volume":"96","author":"Zapatero","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"coi200003r28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.05.029","article-title":"Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology\/American Urological Association guidelines.","volume":"86","author":"Valicenti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"coi200003r29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.prro.2019.04.008","article-title":"Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO\/AUA Guideline Amendment, Executive Summary 2018.","volume":"9","author":"Pisansky","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"coi200003r30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.prro.2019.06.006","article-title":"Seeking consistency in guidelines: level of evidence, trial endpoints, and personalized recommendations.","volume":"9","author":"Spratt","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"coi200003r31","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/bju.2007.99.issue-6","article-title":"Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council\/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.","volume":"99","author":"Parker","year":"2007","journal-title":"BJU Int"},{"issue":"9","key":"coi200003r32","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2763311\/jamaoncology_dess_2020_oi_200003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T18:56:57Z","timestamp":1722625017000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2763311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.0109","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}